Search results
Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfront
FierceBiotech· 6 days agoHarmony Biosciences is adding a suite of epilepsy assets to its pipeline, buying Epygenix for $35 million upfront with more than $600 million in biobucks on the table. The relatively small M ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoBrooklyn, New York, May 03, 2024 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global biomaterial-based vaccines market is analyzed to grow at a CAGR of 17.7% during the forecast period